| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000022120 |
| Receipt No. | R000025501 |
| Official scientific title of the study | Efficacy and safety of tramadol- acetaminophen combination tablets for lumbar canal stenosis |
| Date of disclosure of the study information | 2016/05/10 |
| Last modified on | 2016/04/28 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Efficacy and safety of tramadol- acetaminophen combination tablets for lumbar canal stenosis | |
| Title of the study (Brief title) | Efficacy and safety of tramadol- acetaminophen combination tablets for lumbar canal stenosis | |
| Region |
|
|
| Condition | ||
| Condition | lumbar canal stenosis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Evaluation of the efficacy of tramadol- acetaminophen combination tablets for the pain of the patient with lumbar canal stenosis |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | QOL associated with lumbar back pain and intermittent claudication |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 6 weeks oral administration of tramadol / acetaminophen combination tablets | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The patient who have continious pain or numbness due to lumbar canal steosis
The patient who has intermittent caludication (less than 30 minutes or 2 km) |
|||
| Key exclusion criteria | The patient who have serious disorder
The patient who have malignant tumor The patient who have mental disease |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Morio Matsumoto |
| Organization | Keio University School of Medicine |
| Division name | Department of Orthopaedic Surgery |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo |
| TEL | 03-3353-1211 |
| morio@a5.keio.jp | |
| Public contact | |
| Name of contact person | Nobuyuki Fujita |
| Organization | Keio University School of Medicine |
| Division name | Department of Orthopaedic Surgery |
| Address | 35 Shinanomachi, Shinjuku-ku, Tokyo |
| TEL | 03-3353-1211 |
| Homepage URL | |
| nfujita2007@yahoo.co.jp | |
| Sponsor | |
| Institute | Keio University School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Keio University School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Partially published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025501 |